Trinds is a new contract research organization
Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS) is a specialized contract research organization (CRO).They are a team of clinical trial specialists with focused expertise in neuromuscular and rare disease. They have 15+ years of experience in successful academic and pharma-sponsored clinical trials research and drug development programs. Their goals are centered around our clients and the patient community. Together their team has successfully set-up, run and completed key clinical trial programs. They provide four key areas of support to pharmaceutical, biotechnology industries, and academic investigators and clinical trial sites.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 19, 2016 | Series Unknown | — | 1 | CureDuchenne Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CureDuchenne Ventures | Yes | Series Unknown |